A mathematical model of cell death in multiple sclerosis

This paper imparts a mathematical model of multiple sclerosis (MS) that was created using Biochemical Systems Theory (BST). This method uses mechanisms and initial values from the literature to create a mathematical model of a disease. The model can then be used to test potential drug therapies and to detect possible trigger points for the disease. The focus of this MS model is mainly the action of reactive oxygen and nitrogen species (RONS), the permeability transition pore (PTP), apoptotic factors, and the eventual cell death in the oligodendrocyte. Several treatment methods were applied based on current therapies; however, one treatment, the prevention of the PTP from opening, is completely experimental and showed positive results based on this model. BST is an effective means of studying MS and can be beneficial in testing new therapy ideas.

[1]  Randolph A. Coleman,et al.  In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease , 2010, Journal of Neuroscience Methods.

[2]  P. Reddy,et al.  Is multiple sclerosis a mitochondrial disease? , 2009, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[3]  R. C. Veen,et al.  Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids , 1999, Journal of Neuroimmunology.

[4]  Robert L. Green,et al.  A pragmatic approach to biochemical systems theory applied to an α-synuclein-based model of Parkinson's disease , 2009, Journal of Neuroscience Methods.

[5]  M. Savageau.  Biochemical systems analysis. II. The steady-state solutions for an n-pool system using a power-law approximation. , 1969, Journal of theoretical biology.

[6]  D. Bourdette,et al.  Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis , 2007, Proceedings of the National Academy of Sciences.

[7]  M. Mohsenzadegan,et al.  TGF-β as a promising option in the treatment of multiple sclerosis , 2009, Neuropharmacology.

[8]  Eberhard O. Voit,et al.  Computational Analysis of Biochemical Systems: A Practical Guide for Biochemists and Molecular Biologists , 2000 .

[9]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[10]  R. Gonsette.  Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity , 2008, Journal of the Neurological Sciences.

[11]  George Perry,et al.  Oxidative stress and neurotoxicity. , 2008, Chemical research in toxicology.

[12]  N. Banik,et al.  Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis. , 2008, CNS & neurological disorders drug targets.

[13]  C. Constantinescu,et al.  Current and future disease‐modifying therapies in multiple sclerosis , 2010, International journal of clinical practice.

[14]  A. Hopkins,et al.  Role of caspases in neuronal apoptosis , 2001 .

[15]  M. Parihar,et al.  Mitochondria in multiple sclerosis. , 2008, Frontiers in bioscience : a journal and virtual library.

[16]  S. Komoly,et al.  The involvement of mitochondria in the pathogenesis of multiple sclerosis , 2007, Journal of Neuroimmunology.

[17]  J. Merrill,et al.  The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.

[18]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[19]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[20]  Yukiko Matsuoka,et al.  Using process diagrams for the graphical representation of biological networks , 2005, Nature Biotechnology.